Driving innovation in pet health

As part of Swedencare since 2021, Vetio continues to lead in the development of advanced technologies for companion animals. In their latest initiative, Vetio and APR Pharma announce partnership for the use of Kynosil® in animal health products — an exciting step that reflects our shared commitment to science-driven progress in pet care.

Vetio Animal Health, a leading global animal health contract development and manufacturing organization (CDMO), has partnered with Eytelia, European leader in developing and producing SILICIUM (silicon) based products for health and well-being and its spin-off APR Pharma to bring Kynosil®, a unique and highly innovative Silicium supplement for pet animals to the market.  Silica is an essential mineral that is very hard to access through diet due to poor bioavailability, but we have solved this problem with our patented Kynosil® product. APR Pharma and Vetio Animal Health plan a dog study utilizing Vetio’s soft chew technology.

Vetio Animal Health’s UK and EU Director David Ryder commented: “We are excited to bring this innovative ingredient to our customers through formulated products that will improve the health and wellbeing of pets worldwide. There is significant supporting data in many species, and we will be engaging in further research to demonstrate the impact this technology will have on our beloved pets.”

Maarten De Gussem, Director of APR Pharma, stated: “We are excited to partner with Vetio, a global technology leader in both soft chews and dermatology liquids.  Through this partnership, Vetio, APR Pharma and Eytelia will bring years of combined scientific expertise to formulate the very best skin care, mobility, and other wellness products for pets.”

Vetio Animal Health is a Contract Development and Manufacturing Organization (CDMO) dedicated to Animal Health, specializing in veterinary pharmaceuticals, nutritional supplements, palatants, and topical liquids. With manufacturing sites in the US, Canada, UK, and Ireland, Vetio is committed to the development and manufacturing of products that improve the lives of animals all around the world. Vetio is a wholly owned subsidiary of Swedencare AB.

APR Pharma, a Belgian spin-off of Eytelia, is using the technology developed by Eytelia, to bring solutions to the market of feed supplements for companion animals.

Eytelia is a Belgian company, founded in 1995, and European leader in developing and producing silicium-based food and feed supplements, focusing on beauty, skin care, mobility and bone health with a strong commitment to quality and innovation.